Quest Settles Ravgen Prenatal Test Patent Suit On Eve Of Trial
By Hailey Konnath ( October 7, 2022, 11:07 PM EDT) -- Quest Diagnostics Inc. reached a deal with Ravgen Inc. resolving the small biotech business' claims that Quest infringed its prenatal genetic test patents ahead of a trial set to kick off Tuesday in California federal court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.